COMMUNIQUÉS West-GlobeNewswire

Merit Medical Acquires View Point Medical, Inc., expanding the Merit Therapeutic Oncology Portfolio
01/04/2026
SOUTH JORDAN, Utah, April 01, 2026 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, today announced it has acquired View Point Medical, Inc. (View Point). Through [...]
Venus Concept Announces Completion of Common Stock Sale and Short-Form Merger
01/04/2026
TORONTO, April 01, 2026 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”), a global medical aesthetic technology leader, today announced the successful completion by affiliates of Madryn Asset [...]
Change in Orion Group Executive Team as of 8 April 2026 – Berkeley Vincent appointed Executive Vice President, Innovative Medicines
01/04/2026
ORION CORPORATION STOCK EXCHANGE RELEASE – CHANGES BOARD/MANAGEMENT/AUDITORS 1 APRIL 2026 at 16.00 EEST Change in Orion Group Executive Team as of 8 April 2026 – Berkeley Vincent appointed Executive Vice President, [...]
Nephros Expands Water Safety Capabilities With ASSE 12080 Certified Water Management Planning Expertise
01/04/2026
New capability adds consultative support and strengthens Nephros’ broader water safety offering SOUTH ORANGE, N.J., April 01, 2026 (GLOBE NEWSWIRE) -- Nephros, Inc. (Nasdaq: NEPH), a leading water technology company [...]
Oncolytics Biotech® Completes Domicile Change to the United States
01/04/2026
SAN DIEGO, April 01, 2026 (GLOBE NEWSWIRE) -- Oncolytics Biotech ® Inc. (Nasdaq: ONCY) (“Oncolytics” or the “Company”), a clinical-stage immunotherapy company developing pelareorep, today announced the completion of the [...]
Noom Acquires Licensed 503A Pharmacy, Accelerating the Next Era of Preventive Care and Enabling Noom’s Expansion Beyond Weight Health
01/04/2026
As approved peptide-based therapies gain broader adoption, Noom’s acquisition of Tailor Made Compounding—its first major acquisition—accelerates its expansion into healthy aging PRINCETON, N.J., April 01, 2026 (GLOBE [...]
Femasys Appoints John Canning as Chief Operating Officer to Drive Operational Execution and Advance Commercial Growth
01/04/2026
ATLANTA, April 01, 2026 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a leading biomedical innovator focused on making fertility and non-surgical permanent birth control more accessible and cost-effective for women [...]
J-Star Holding Announces Return of Jonathan Chiang as Chief Executive Officer
01/04/2026
TAICHUNG CITY, Taiwan, April 01, 2026 (GLOBE NEWSWIRE) -- J-Star Holding Co., Ltd. (Nasdaq: YMAT) (“J-Star” or the “Company”), a leading provider of innovative carbon fiber and composite solutions serving diverse [...]
Beyond Air Expands Commercial Access for LungFit® PH Through a Purchasing Agreement with a Top 3 National Group Purchasing Organization (GPO)
01/04/2026
GARDEN CITY, N.Y., April 01, 2026 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR), a commercial-stage medical device and biopharmaceutical company focused on harnessing the power of nitric oxide (NO) to improve [...]
Johns Hopkins Health Plans Sits Down with Dundalk Seniors to Champion Community Connection
01/04/2026
Priority Partners and Advantage MD Join Seniors for an Afternoon of Food, Music and Community HANOVER, Md., April 01, 2026 (GLOBE NEWSWIRE) -- Johns Hopkins Health Plans joined Neighborhood Companions, Inc. at the [...]
OneMedNet, Onco-Innovations and Inka Health Announces Collaboration Aimed to Accelerate Potential for Oncology Drug Development Using Real-World Data and AI
01/04/2026
MINNEAPOLIS, April 01, 2026 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (the “OneMedNet,” the “Company,” “we,” “us” or “our”), a leading provider of regulatory decision-grade, AI-ready Real-World Data (RWD [...]
Cannabix Technologies Announces Delivery of Marijuana Breath Test (MBT) to Virginia based Industrial Manufacturing Client
01/04/2026
VANCOUVER, British Columbia, April 01, 2026 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTCID: BLOZF) (Frankfurt: 8CT) (the “Company” or “Cannabix”) developer of marijuana and alcohol breath testing [...]
Senti Biosciences Announces Publication in Cell Systems Demonstrating Advanced Logic-Gated CAR Design for Cell Therapies
01/04/2026
SOUTH SAN FRANCISCO, Calif., April 01, 2026 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio”), a clinical-stage biotechnology company developing next-generation cell and gene therapies using its [...]
FeraMAX est le supplemént de fer le plus recommandé au Canada depuis 11 années consécutives
01/04/2026
MISSISSAUGA, Ontario, 01 avr. 2026 (GLOBE NEWSWIRE) -- BioSyent inc. (« BioSyent », Bourse de croissance TSX : RX) est heureuse d’annoncer que FeraMAX MD a été désigné supplément de fer en vente libre le plus recommandé [...]
Polaryx Therapeutics To Participate In The 25th Annual Needham Virtual Healthcare Conference
01/04/2026
PARAMUS, NJ, April 01, 2026 (GLOBE NEWSWIRE) -- Polaryx Therapeutics, Inc. (Nasdaq: PLYX), a clinical-stage biotechnology company developing novel, disease-modifying therapies for rare, pediatric lysosomal storage [...]
FeraMAX is Canada's Top-Ranked Iron Supplement for 11 Consecutive Years
01/04/2026
MISSISSAUGA, Ontario, April 01, 2026 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) is pleased to announce that FeraMAX ® has been named the #1 recommended over-the-counter (OTC) iron supplement brand [...]
Highridge Medical Announces Landmark Positive Policy Decision for The Tether™ Vertebral Body Tethering System
01/04/2026
UnitedHealthcare® policy, exclusively covering The Tether as “medically necessary” for the treatment of pediatric scoliosis, brings coverage to additional patients nationwide WESTMINSTER, Colo., April 01, 2026 (GLOBE [...]
Clover Health Announces Departure of Chief Financial Officer and Appointment of Interim Chief Financial Officer; Reiterates Most Recently Issued Financial Guidance for Full Fiscal Year 2026
01/04/2026
WILMINGTON, Del., April 01, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover” or the “Company”), a physician enablement company committed to bringing access to great healthcare to [...]
Actinogen commences open-label phase of XanaMIA Alzheimer’s trial and provides business update
01/04/2026
Randomized phase of XanaMIA pivotal trial of oral Xanamem 10 mg remains on track for topline final results in November 2026 SYDNEY, April 01, 2026 (GLOBE NEWSWIRE) -- Actinogen Medical Limited (ASX: ACW) announces that [...]

Pages